Xeris Pharmaceuticals

Xeris Pharmaceuticals

Xeris Pharmaceuticals

Xeris Pharmaceuticals is a specialty company developing patient-friendlyinjectables for indications in diabetes, epilepsy, and immunology.
Founded
2005
Raised
$186.9M
Follow us
Alexa global traffic share
Latest funding Show all
$85,500,000
IPO - 2018
$41,000,000
Venture capital (Series C) - 2017
Redmile Group Deerfield Deerfield Partners +3
Team Size
2
Employees
$85,500,000 IPO
PE HUB

Xeris Pharmaceuticals goes public

Stock markets
$41,000,000 Venture capital (Series C)
Xconomy

Austin Biotech Xeris Names Edick CEO, Raises $41M in Series C Round

Health Funding
$41,000,000 Venture capital (Series C)
FinSMEs

Xeris Pharmaceuticals Closes $41M Series C Financing

Funding Health